<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Deracoxib</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Oral Dosage Form New Animal Drugs; Deracoxib</h1>
    <p class="timestamp">Published: 2012-01-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health U.S., Inc. The supplemental NADA provides for veterinary prescription use of deracoxib tablets in dogs for the control of postoperative pain and inflammation associated with dental surgery and the addition of a 12-milligram (mg) size tablet.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-1622</p>
    <p><strong>Publication Date:</strong> 2012-01-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/01/26/2012-1622/oral-dosage-form-new-animal-drugs-deracoxib">https://www.federalregister.gov/documents/2012/01/26/2012-1622/oral-dosage-form-new-animal-drugs-deracoxib</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-1622</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
